| 000 | 01755 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250517185739.0 | ||
| 264 | 0 | _c20180821 | |
| 008 | 201808s 0 0 eng d | ||
| 022 | _a1468-3083 | ||
| 024 | 7 |
_a10.1111/jdv.14624 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKanti, V | |
| 245 | 0 | 0 |
_aEvidence-based (S3) guideline for the treatment of androgenetic alopecia in women and in men - short version. _h[electronic resource] |
| 260 |
_bJournal of the European Academy of Dermatology and Venereology : JEADV _cJan 2018 |
||
| 300 |
_a11-22 p. _bdigital |
||
| 500 | _aPublication Type: Letter | ||
| 650 | 0 | 4 |
_a5-alpha Reductase Inhibitors _xtherapeutic use |
| 650 | 0 | 4 |
_aAlopecia _xtherapy |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 |
_aDutasteride _xtherapeutic use |
| 650 | 0 | 4 | _aEvidence-Based Medicine |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFinasteride _xtherapeutic use |
| 650 | 0 | 4 |
_aHair _xtransplantation |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aLow-Level Light Therapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMinoxidil _xtherapeutic use |
| 650 | 0 | 4 | _aOutcome Assessment, Health Care |
| 650 | 0 | 4 | _aPlatelet-Rich Plasma |
| 650 | 0 | 4 | _aPractice Guidelines as Topic |
| 650 | 0 | 4 |
_aVasodilator Agents _xtherapeutic use |
| 700 | 1 | _aMessenger, A | |
| 700 | 1 | _aDobos, G | |
| 700 | 1 | _aReygagne, P | |
| 700 | 1 | _aFinner, A | |
| 700 | 1 | _aBlumeyer, A | |
| 700 | 1 | _aTrakatelli, M | |
| 700 | 1 | _aTosti, A | |
| 700 | 1 | _aDel Marmol, V | |
| 700 | 1 | _aPiraccini, B M | |
| 700 | 1 | _aNast, A | |
| 700 | 1 | _aBlume-Peytavi, U | |
| 773 | 0 |
_tJournal of the European Academy of Dermatology and Venereology : JEADV _gvol. 32 _gno. 1 _gp. 11-22 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/jdv.14624 _zAvailable from publisher's website |
| 999 |
_c27828178 _d27828178 |
||